Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma
- PMID: 18819787
- DOI: 10.1016/j.rmed.2008.08.010
Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma
Abstract
Objective: To evaluate the effects of weight change on asthma control, asthma-related quality of life, number of steroid bursts, and exacerbation of asthma symptoms in a population of adult patients with severe or difficult-to-treat asthma who participated in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
Methods: We categorized 2396 TENOR patients > or = 18 years into three groups (> or = 5 lb loss, stable, > or = 5 lb gain), based on a +/-5 lb (2.27 kg) difference between baseline and 12-month follow-up weight. We used proportional odds and logistic regression models to evaluate the effect of weight change on Asthma Therapy Assessment Questionnaire (ATAQ) and Asthma Quality of Life Questionnaire (AQLQ) scores, exacerbations, and steroid bursts at the 12-month follow-up.
Results: Asthma patients who gained > or = 5 lb (2.27 kg) during the 12-month interval between baseline and follow-up reported poorer asthma control (adjusted odds ratio [OR]: 1.22; 95% confidence interval [CI]: 1.01-1.49; p=0.04), worse quality of life (least square means: -0.18; 95% CI: -0.30 to -0.06; p=0.003), and a greater number of steroid bursts (OR: 1.31; CI: 1.04-1.66; p=0.02) than patients who maintained their baseline weight or lost > or = 5 lb (2.27 kg).
Conclusion: Increased weight is associated with worse asthma-related health outcomes. Strategies to prevent weight gain could help patients achieve better asthma control and improve asthma-related quality of life.
Similar articles
-
Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients.Allergy. 2007 Jun;62(6):655-60. doi: 10.1111/j.1398-9995.2007.01383.x. Allergy. 2007. PMID: 17508970
-
Recent asthma exacerbations: a key predictor of future exacerbations.Respir Med. 2007 Mar;101(3):481-9. doi: 10.1016/j.rmed.2006.07.005. Epub 2006 Aug 17. Respir Med. 2007. PMID: 16914299
-
Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.Ann Allergy Asthma Immunol. 2004 Jan;92(1):32-9. doi: 10.1016/S1081-1206(10)61707-3. Ann Allergy Asthma Immunol. 2004. PMID: 14756462
-
Difficult asthma in adults: recognition and approaches to management.Intern Med J. 2005 Sep;35(9):543-7. doi: 10.1111/j.1445-5994.2005.00901.x. Intern Med J. 2005. PMID: 16105156 Review.
-
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review.Allergy. 2008 Aug;63(8):1015-30. doi: 10.1111/j.1398-9995.2008.01823.x. Allergy. 2008. PMID: 18691305 Review.
Cited by
-
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.J Allergy Clin Immunol. 2012 Aug;130(2):332-42.e10. doi: 10.1016/j.jaci.2012.04.014. Epub 2012 Jun 12. J Allergy Clin Immunol. 2012. PMID: 22694932 Free PMC article.
-
Protocol for a systematic review to identify and weight the indicators of risk of asthma exacerbations in children aged 5-12 years.NPJ Prim Care Respir Med. 2017 Jan 5;27:16088. doi: 10.1038/npjpcrm.2016.88. NPJ Prim Care Respir Med. 2017. PMID: 28055001 Free PMC article. No abstract available.
-
Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence.Pulm Ther. 2022 Dec;8(4):343-358. doi: 10.1007/s41030-022-00203-x. Epub 2022 Nov 22. Pulm Ther. 2022. PMID: 36417159 Free PMC article. Review.
-
Asthma.Nat Rev Dis Primers. 2015 Sep 10;1(1):15025. doi: 10.1038/nrdp.2015.25. Nat Rev Dis Primers. 2015. PMID: 27189668 Free PMC article. Review.
-
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort.Curr Respir Care Rep. 2012 Dec;1(4):259-269. doi: 10.1007/s13665-012-0025-x. Epub 2012 Sep 20. Curr Respir Care Rep. 2012. PMID: 23136642 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical